| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/04/2023 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 05/09/2023 | -3.51% | Goldman Sachs | $6.25 → $5.5 | Maintains | Sell |
| 05/08/2023 | 14.04% | Piper Sandler | $9 → $6.5 | Maintains | Neutral |
| 05/08/2023 | 22.81% | Keefe, Bruyette & Woods | $8 → $7 | Maintains | Market Perform |
| 05/08/2023 | 40.35% | Raymond James | $10 → $8 | Maintains | Outperform |
| 04/24/2023 | 40.35% | Keefe, Bruyette & Woods | $9 → $8 | Maintains | Market Perform |
| 04/11/2023 | 9.65% | Goldman Sachs | $9 → $6.25 | Maintains | Sell |
| 04/10/2023 | 9.65% | Goldman Sachs | $9 → $6.25 | Maintains | Sell |
| 02/17/2023 | 57.89% | Goldman Sachs | $8 → $9 | Maintains | Sell |
| 01/20/2023 | 75.44% | Raymond James | $13 → $10 | Maintains | Outperform |
| 12/12/2022 | 40.35% | Goldman Sachs | $9 → $8 | Downgrades | Neutral → Sell |
| 11/08/2022 | 57.89% | Goldman Sachs | $10.25 → $9 | Maintains | Neutral |
| 10/31/2022 | 128.07% | Raymond James | $15 → $13 | Maintains | Outperform |
| 10/20/2022 | 163.16% | Raymond James | $16 → $15 | Maintains | Outperform |
| 10/19/2022 | 79.82% | Goldman Sachs | $13.25 → $10.25 | Maintains | Neutral |
| 10/07/2022 | 75.44% | Piper Sandler | $12 → $10 | Maintains | Neutral |
| 07/22/2022 | 180.7% | Raymond James | $18 → $16 | Maintains | Outperform |
| 04/26/2022 | 215.79% | Raymond James | $21 → $18 | Maintains | Outperform |
| 04/18/2022 | 163.16% | Piper Sandler | $20 → $15 | Downgrades | Overweight → Neutral |
| 04/05/2022 | 215.79% | Goldman Sachs | → $18 | Initiates Coverage On | → Neutral |
| 03/10/2022 | 198.25% | Wolfe Research | $22 → $17 | Downgrades | Outperform → Peer Perform |
| 11/08/2021 | 268.42% | Raymond James | $20 → $21 | Maintains | Outperform |
| 08/09/2021 | 250.88% | Raymond James | $18 → $20 | Maintains | Outperform |
| 06/15/2021 | 285.96% | Wolfe Research | → $22 | Initiates Coverage On | → Outperform |
| 02/19/2021 | 110.53% | Piper Sandler | $7.5 → $12 | Upgrades | Neutral → Overweight |
| 02/19/2021 | 92.98% | Goldman Sachs | $10 → $11 | Maintains | Buy |
| 01/22/2021 | 92.98% | Raymond James | $10 → $11 | Maintains | Outperform |
| 09/01/2020 | 5.26% | Wedbush | $8 → $6 | Maintains | Neutral |
| 07/29/2020 | 75.44% | Raymond James | $14 → $10 | Maintains | Outperform |
| 05/28/2020 | -12.28% | Piper Sandler | $4.5 → $5 | Maintains | Neutral |
| 05/08/2020 | -21.05% | Keefe, Bruyette & Woods | $4 → $4.5 | Maintains | Market Perform |
| 04/14/2020 | -12.28% | Piper Sandler | $12.5 → $5 | Maintains | Neutral |
| 02/14/2020 | 116.67% | Wedbush | $13 → $12.35 | Downgrades | Outperform → Neutral |
| 02/14/2020 | 119.3% | Piper Sandler | $15 → $12.5 | Downgrades | Overweight → Neutral |
| 10/18/2019 | 163.16% | B of A Securities | → $15 | Initiates Coverage On | → Buy |
| 07/11/2019 | 145.61% | Compass Point | → $14 | Initiates Coverage On | → Buy |
| 02/28/2019 | 180.7% | Wedbush | $20 → $16 | Maintains | Outperform |
| 10/26/2018 | 215.79% | Raymond James | $20 → $18 | Maintains | Outperform |
What is the target price for Newmark Group (NMRK)?
The latest price target for Newmark Group (NASDAQ: NMRK) was reported by Raymond James on October 4, 2023. The analyst firm set a price target for $0.00 expecting NMRK to fall to within 12 months (a possible -100.00% downside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Newmark Group (NMRK)?
The latest analyst rating for Newmark Group (NASDAQ: NMRK) was provided by Raymond James, and Newmark Group downgraded their market perform rating.
When is the next analyst rating going to be posted or updated for Newmark Group (NMRK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Newmark Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Newmark Group was filed on October 4, 2023 so you should expect the next rating to be made available sometime around October 4, 2024.
Is the Analyst Rating Newmark Group (NMRK) correct?
While ratings are subjective and will change, the latest Newmark Group (NMRK) rating was a downgraded with a price target of $0.00 to $0.00. The current price Newmark Group (NMRK) is trading at is $5.70, which is out of the analyst's predicted range.